ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 31 filers reported holding ARGOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 1,351 | -18.2% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 1,651 | -92.2% | 0.00% | – |
| Q2 2017 | $8,000 | -60.0% | 21,250 | -54.8% | 0.00% | – |
| Q1 2017 | $20,000 | +122.2% | 47,017 | +2624.0% | 0.00% | – |
| Q4 2016 | $9,000 | +125.0% | 1,726 | +115.8% | 0.00% | – |
| Q3 2016 | $4,000 | -20.0% | 800 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | +400.0% | 800 | +52.7% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 524 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 524 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | -40.0% | 524 | -12.7% | 0.00% | – |
| Q1 2015 | $5,000 | -16.7% | 600 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | +50.0% | 600 | +50.0% | 0.00% | – |
| Q3 2014 | $4,000 | +100.0% | 400 | +33.3% | 0.00% | – |
| Q2 2014 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $2,377,000 | 6.93% |
| Pharmstandard International S.A. | 5,120,604 | $919,000 | 2.68% |
| SANDERS MORRIS HARRIS LLC | 132,212 | $23,000 | 0.01% |
| WEDBUSH SECURITIES INC | 112,000 | $20,000 | 0.00% |
| WASATCH ADVISORS LP | 665,831 | $120,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 149,999 | $27,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $23,000 | 0.00% |
| STATE STREET CORP | 11,900 | $2,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 180,032 | $32,000 | 0.00% |
| GUGGENHEIM CAPITAL LLC | 27,984 | $5,000 | 0.00% |